丽珠医药(01513.HK)：截至8月31日通过集中竞价交易回购共计1338.31万股A股

Group 1 - The company, Lijun Pharmaceutical (01513.HK), announced a share buyback program, repurchasing a total of 13.3831 million A-shares, which represents 1.48% of the company's total share capital [1] - The highest purchase price during the buyback was RMB 41.99 per share, while the lowest was RMB 33.21 per share [1] - The total amount of funds used for the buyback was RMB 491 million, excluding transaction fees [1]